Videos

Panelists explain why active nutrition has topped the growth charts for 5 straight years, and what an aging cohort of sports nutrition consumers means for formulators and brand owners.

Joey Savage, Founder of Savage Nutrition, previews his talk on mitochondrial health and longevity ahead of The Outlook on Active Nutrition.

In the seventh episode, Nicholas Saraceno traces how ingredients like ashwagandha, fenugreek, and shatavari moved from traditional medicine systems into mainstream supplement formulations, and why the same adaptogen category now driving double-digit market growth is also facing new scrutiny over sourcing and raw material standards.

Ashish Talati discusses the proposed GRAS rule, and what industry needs to understand about complying with the rule should it be finalized.

Rutgers' director of sports nutrition, Katie Salomone, breaks down how collagen protocols differ between injury recovery and injury prevention, where the ingredient science still falls short, and what manufacturers get wrong when formulating for elite athletes, ahead of her session at the upcoming Outlook on Active Nutrition conference.

In the sixth episode, Nicholas Saraceno breaks down why collagen, skin microbiome science, and nutricosmetics are converging into one of the fastest-growing categories in the industry, and why claims substantiation remains the biggest gap between where the science is and where the marketing tends to go.

Ahead of her session at the upcoming Outlook on Active Nutrition conference, Pink Catalyst Consulting founder Diana Morgan breaks down how fast-moving, influencer-driven brands often treat regulatory as an afterthought, what a realistic first step toward clinical validation looks like for smaller brands, and why retailers are quietly tightening compliance standards.

Spencer Lynn breaks down why various brands have built lasting loyalty from the ground up, while many celebrity-backed drink launches fade fast.

In this preview of the upcoming The Outlook on Active Nutrition, Maura MacDonald MS, RD, CSSD, LDN, shares insights on formulating for the female athlete.

From skits to serious ingredient deep dives, Spencer Lynn explains how content built for entertainment first is reshaping what functional beverage consumers actually expect a product to deliver.

Beta-alanine is known in sports nutrition for its role in muscular endurance and recovery, where it often goes hand-in-hand with ingredients like creatine, BCAAs, and electrolytes. However, it hasn’t had the same broad proliferation for general health and wellness despite numerous clinical studies showing benefits for brain health, focus, bones, joints, and heart health. Listen as Mark A. LeDoux, a 50+ year industry vet, discusses beta alanine and recounts a breakthrough in delivery technology to remove barriers to formulation, making beta-alanine an ingredient to watch.

From beta-alanine's clinical track record to the next wave of life-stage formulation, sports dietician Maura MacDonald discusses supplement research and women's nutritional needs.

In the fifth episode, Nicholas Saraceno walks through why natural colors, upcycled ingredients, and sustainable sourcing have become inseparable from consumer trust, and what that shift means for manufacturers deciding where to invest first.

Matts Johansen explains why traceability, not just quotas, may be the real safeguard against supply chain "shortcuts" as omega-3 sourcing comes under pressure, along with why he sees marine-protected areas as a long-term ally for industry.

Matts Johansen, CEO of Aker BioMarine, says the coming shortage isn't about price, but about supply disappearing entirely.

Gelita's North America marketing communications manager breaks down how rising GLP-1 usage is accelerating demand for nutrient-dense, portion-smart products, the tradeoffs between collagen and complete proteins in bar formulations, and what responsible claims substantiation looks like for collagen peptides.

David Foreman, Hank Ramsey, and Irfan Qureshi close out their Peer Exchange with a candid look at organic certification, global sourcing, tariffs, and the innovations shaping the future of the nutraceutical industry.

David Foreman, Hank Ramsey, and Irfan Qureshi dig into the technical side of dosage design—exploring how solubility, pH, and stability determine whether an ingredient calls for immediate, delayed, or sustained release.

Leading industry professionals David Foreman, Hank Ramsey, and Irfan Qureshi unpack why gummies, soft chews, powders, and shots are reshaping supplement formulation—and what it really takes to get an alternative delivery format right.

What are the main differences between using plant-based or animal-based capsules? This conversation details the decision-making behind this choice and the potentials costs and benefits of that choice.

Industry veterans discuss the decision-making behind choosing between capsules or tablets when formulating nutraceuticals.

NPA's Daniel Fabricant, PhD, draws on his time as former director of FDA's Division of Dietary Supplement Programs to explain the agency's regulatory mindset, then lays out the association's near-term priorities.

Stanford's Michael Fredericson, MD, FACSM, unpacks creatine's emerging role in memory and cognition and why the basics still matter most for healthy aging.

Stanford's Michael Fredericson, MD, explains creatine's role in longevity and muscle strength, highlighting why creatine can be especially relevant for women.

In the fourth episode, Nicholas Saraceno unpacks why negative media coverage of omega-3 research doesn't always tell the full story, and what finished product manufacturers and consumers alike should understand about reading past a headline to the actual study design.

NPA's president and CEO explains how the organization decides when to challenge industry-critical research, breaks down what he sees as “flawed” methodology in a recent glucosamine-Alzheimer's study, and weighs in on a lawsuit that could reshape how supplement health claims are made.

As a new lawsuit challenges FDA's food-only interpretation of authoritative health claims, Steve Mister, president and CEO of CRN, discusses its own First Amendment case over New York's age restrictions and how Sergeant Searchlight fits into serious policy advocacy.

The association’s president and CEO explains the strategy behind Sergeant Searchlight, and why voluntary product databases fall short of the mandatory registry the industry has pursued for 6 years.

Susan Kleiner, PhD, explains how evidence favors creatine monohydrate, while newer forms lack superior outcomes; major gaps remain in data for children, gummies, fertility, and pregnancy.

Susan Kleiner, PhD, explains how creatine may support women through hormonal transitions, aiding mood, cognition, strength, and recovery.